FIRST MANHATTAN CO. LLC. - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 17 filers reported holding ACER THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$11,000
-96.5%
3,000
-76.9%
0.00%
-100.0%
Q1 2019$315,000
+20.7%
13,0000.0%0.00%0.0%
Q4 2018$261,000
-5.8%
13,000
+44.4%
0.00%
+100.0%
Q3 2018$277,000
+156.5%
9,000
+80.0%
0.00%0.0%
Q2 2018$108,000
+12.5%
5,0000.0%0.00%0.0%
Q1 2018$96,000
+39.1%
5,0000.0%0.00%
Q4 2017$69,0005,0000.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 250,518$722,0000.59%
Nantahala Capital Management 990,655$2,853,0000.09%
GSA CAPITAL PARTNERS LLP 82,421$237,0000.04%
FEDERATED HERMES, INC. 117,673$339,0000.00%
BNP PARIBAS FINANCIAL MARKETS 179$516,0000.00%
Horan Securities, Inc. 24$00.00%
OSAIC HOLDINGS, INC. 200$1,0000.00%
BANK OF AMERICA CORP /DE/ 3$00.00%
WELLS FARGO & COMPANY/MN 29$00.00%
NORTHERN TRUST CORP 31,083$90,0000.00%
View complete list of ACER THERAPEUTICS INC shareholders